Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail.
G. Marconi Chair of Dermatology and Venereology, University of Rome, Rome, Italy. g.buggiani@gmail.com
Gionata
G
Buggiani
Angelo Massimiliano
AM
D'Erme
Alena
A
Krysenka
Leonardo
L
Pescitelli
Torello
T
Lotti
Francesca
F
Prignano
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products / Q000627:therapeutic use*; D003873:Dermatitis, Exfoliative / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D000069549:Ustekinumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha; D000069549:Ustekinumab